The Current Ratio as of December 2024 (TTM) for Tonix Pharmaceuticals Holding Corp. (TNXP) is 3.33

According to Tonix Pharmaceuticals Holding Corp.’s latest financial reports and current stock price. The company's current Current Ratio is 3.33. This represents a change of 57.12% compared to the average of 2.12 of the last 4 quarters.

Tonix Pharmaceuticals Holding Corp. (TNXP) Historical Current Ratio (quarterly & annually)

How has TNXP Current Ratio performed in the past?

The mean historical Current Ratio of Tonix Pharmaceuticals Holding Corp. over the last ten years is 8.37. The current 3.33 Current Ratio has changed 3.88% with respect to the historical average. Over the past ten years (40 quarters), TNXP's Current Ratio was at its highest in in the March 2021 quarter at 28.73. The Current Ratio was at its lowest in in the June 2024 quarter at 1.15.

Tonix Pharmaceuticals Holding Corp. (TNXP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Tonix Pharmaceuticals Holding Corp. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tonix Pharmaceuticals Holding Corp. (TNXP) Average Current Ratio

How has TNXP Current Ratio performed in the past?

The current Current Ratio of Tonix Pharmaceuticals Holding Corp. (TNXP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Tonix Pharmaceuticals Holding Corp. (TNXP) Current Ratio vs. Peers

How is TNXP’s Current Ratio compared to its peers?

Tonix Pharmaceuticals Holding Corp.’s Current Ratio is greater than Sonnet BioTherapeutics Holdings, Inc. (0.66), greater than Onconova Therapeutics, Inc. (1.07), greater than Palisade Bio, Inc. (3.31), less than iBio, Inc. (3.37), greater than Jaguar Health, Inc. (1.84), less than Acasti Pharma Inc. (7.86), less than Diffusion Pharmaceuticals Inc. (15.04), greater than Vaxart, Inc. (0.83), greater than VBI Vaccines Inc. (0.34), less than Bright Minds Biosciences Inc. (35.08), less than Virax Biolabs Group Limited (25.94), greater than Novavax, Inc. (0.93), less than Inovio Pharmaceuticals, Inc. (3.88), less than Enveric Biosciences, Inc. (5.17), less than CohBar, Inc. (15.69),

Build a custom stock screener for Tonix Pharmaceuticals Holding Corp. (TNXP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tonix Pharmaceuticals Holding Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tonix Pharmaceuticals Holding Corp. (TNXP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tonix Pharmaceuticals Holding Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.